Evidence map›Paper›PMID 42903939›Full record

ArticleRSC chemical biology2026

Lipid interactions couple turnercyclamycin antibacterial activity with carbohydrate-active enzyme packaging in membrane vesicles.

Bailey W Miller, Albebson L Lim, Mark T Gasser, Zhenjian Lin, Daniel L Distel, Eric W Schmidt

Abstract read
In one paragraph

Article in RSC chemical biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Bailey W MillerDepartment of Medicinal Chemistry, University of Utah Salt Lake City UT 84112 USA ews1@utah.edu.ORCID https://orcid.org/0000-0003-3204-3235
Albebson L LimDepartment of Medicinal Chemistry, University of Utah Salt Lake City UT 84112 USA ews1@utah.edu.ORCID https://orcid.org/0000-0001-9972-3425
Mark T GasserJohns Hopkins Applied Physics Laboratory Laurel MD 20723 USA.ORCID https://orcid.org/0000-0002-9396-4954
Zhenjian LinDepartment of Medicinal Chemistry, University of Utah Salt Lake City UT 84112 USA ews1@utah.edu.ORCID https://orcid.org/0000-0002-6069-5217
Daniel L DistelOcean Genome Legacy Center, Northeastern University Nahant MA 01908 USA d.distel@northeastern.edu.ORCID https://orcid.org/0000-0002-3860-194X
Eric W SchmidtDepartment of Medicinal Chemistry, University of Utah Salt Lake City UT 84112 USA ews1@utah.edu.ORCID https://orcid.org/0000-0001-5839-694X

Funding

Microbial Ecology-Guided Discovery of Antibacterial DrugsR01AI162943 · NIAID · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI Eric W Schmidt · 2022 to 2026
$3.2M
NIAID NIH HHS R01 AI162943
6 · The paper itself

Abstract

Turnercyclamycins from shipworm-symbiotic bacteria are lipopeptides with promise for targeting bacterial infections. Their mechanisms of action and resistance suggest an essential role for lipid interactions. We purified analogs with lipid chain lengths ranging from C12 to C16 and tested them against

Identifiers

PMID42903939
PMCPMC13682526

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.